These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 9768715

  • 41. Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test.
    Mene-Afejuku TO, Balogun MO, Akintomide AO, Adebayo RA.
    Vasc Health Risk Manag; 2017; 13():71-79. PubMed ID: 28280349
    [Abstract] [Full Text] [Related]

  • 42. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
    Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN.
    Circulation; 1996 Jun 15; 93(12):2128-34. PubMed ID: 8925581
    [Abstract] [Full Text] [Related]

  • 43. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
    Viswanathan K, Suszko AM, DAS M, Jackson N, Gollob M, Cameron D, Spears D, Woo A, Rakowski H, Khurana M, Chauhan VS.
    Pacing Clin Electrophysiol; 2016 Jul 15; 39(7):642-51. PubMed ID: 27027856
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH, Klingenheben T, Zabel M, Schöpperl M, Mauss O.
    J Am Coll Cardiol; 1999 Jun 15; 33(7):1895-902. PubMed ID: 10362190
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
    Burckhardt D, Robertson A, Hoffmann A, Pfisterer M.
    J Clin Pharmacol; 1991 Nov 15; 31(11):1105-8. PubMed ID: 1753016
    [Abstract] [Full Text] [Related]

  • 49. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Nov 15; 70(11):1099-110. PubMed ID: 23180517
    [Abstract] [Full Text] [Related]

  • 50. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.
    Wang S, Cui H, Song C, Zhu C, Wu R, Meng L, Yu Q, Huang X, Wang S.
    Heart Rhythm; 2019 May 15; 16(5):694-701. PubMed ID: 30576881
    [Abstract] [Full Text] [Related]

  • 51. Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging).
    Marine JE, Shetty V, Chow GV, Wright JG, Gerstenblith G, Najjar SS, Lakatta EG, Fleg JL.
    J Am Coll Cardiol; 2013 Aug 13; 62(7):595-600. PubMed ID: 23747767
    [Abstract] [Full Text] [Related]

  • 52. Left ventricular twist in hypertrophic cardiomyopathy : Predictor of nonsustained ventricular tachycardia.
    Candan O, Gecmen C, Kalaycı A, Bayam E, Guner A, Gunduz S, Cersit S, Ozkan M.
    Herz; 2019 May 13; 44(3):238-246. PubMed ID: 29038823
    [Abstract] [Full Text] [Related]

  • 53. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    Bui AH, Cannon CP, Steg PG, Storey RF, Husted S, Guo J, Im K, James SK, Michelson EL, Himmelmann A, Held C, Varenhorst C, Wallentin L, Scirica BM.
    Circ Arrhythm Electrophysiol; 2016 Feb 13; 9(2):e002951. PubMed ID: 26810596
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
    N Engl J Med; 2005 Jan 20; 352(3):225-37. PubMed ID: 15659722
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H, Auricchio A, Reek S, Geller C.
    Am J Cardiol; 1999 Mar 11; 83(5B):91D-97D. PubMed ID: 10089848
    [Abstract] [Full Text] [Related]

  • 58. Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction.
    Jiménez-Candil J, Hernández J, Perdiguero P, Martín A, Moríñigo J, Bravo L, Durán O, Sánchez PL.
    Am J Cardiol; 2016 Nov 15; 118(10):1503-1510. PubMed ID: 27634031
    [Abstract] [Full Text] [Related]

  • 59. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG, Felder SD, Figura I, Johnston DR, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1987 Jan 15; 9(1):169-74. PubMed ID: 3794093
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.